AMLX Amylyx Pharmaceuticals Inc.

18.52
-1.77  -9%
Previous Close 20.29
Open 20.12
52 Week Low 16
52 Week High 23.16
Market Cap $1,045,750,561
Shares 56,466,013
Float 32,984,512
Enterprise Value $920,311,560
Volume 200,160
Av. Daily Volume 118,182
Stock charts supplied by TradingView

Drug Pipeline

Drug Stage Notes
AMX0035
Wolfram Syndrome
Phase 1
Phase 1
IND expected to be submitted 1H 2022.
AMX0035
Alzheimer's Disease
Phase 2
Phase 2
Phase 2 data reported in 4Q 2021.
AMX0035
Amyotrophic lateral sclerosis
NDA Filing
NDA Filing
NDA submitted in 4Q 2021. Accepted for priority review in 4Q 2021.